Biomarin Pharmaceuticals (BMRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | BMRN | AMGN | BMY | GILD | MRNA |
Company | Biomarin Pharmaceuticals | Amgen Inc | Bristol-Myers Squibb Company | Gilead Sciences Inc | Moderna Inc |
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
Open | 71.82 | 335.15 | 49.29 | 83.26 | 67.60 |
High | 71.82 | 337.49 | 49.53 | 83.61 | 67.91 |
Low | 70.96 | 334.27 | 49.06 | 82.75 | 66.31 |
Last | 71.35 | 336.50 | 49.33 | 83.39 | 65.74 |
Change | -0.06 | +0.55 | +0.31 | -0.51 | -2.28 |
% Change | -0.08% | +0.16% | +0.63% | -0.61% | -3.35% |
Volume | 222,318 | 892,571 | 5,612,699 | 2,578,615 | 1,249,045 |
20-Day Average Volume | 2,264,169 | 1,693,601 | 8,377,887 | 6,493,408 | 5,301,860 |
Previous Close | 71.41 | 335.95 | 49.02 | 83.90 | 68.02 |
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
Has Options | Yes | Yes | Yes | Yes | Yes |
Technicals | |||||
20-Day Moving Average | 83.58 | 330.12 | 49.17 | 80.43 | 74.38 |
20-Day Raw Stochastic | 10.67% | 80.92% | 54.30% | 79.62% | 14.25% |
20-Day Relative Strength | 28.55% | 56.86% | 54.92% | 67.70% | 31.60% |
Weighted Alpha | -23.93 | +26.69 | -10.73 | +16.61 | -37.11 |
Today's Opinion | 56% Sell | 96% Buy | 72% Buy | 88% Buy | 88% Sell |
Previous Opinion | 56% Sell | 96% Buy | 56% Buy | 88% Buy | 88% Sell |
Last Month's Opinion | 56% Buy | 88% Buy | 40% Buy | 56% Buy | 56% Sell |
Performance | |||||
5-Days | |||||
%Chg | -15.88% since 09/13/24 | +0.82% since 09/13/24 | +0.16% since 09/13/24 | +0.30% since 09/13/24 | -1.90% since 09/13/24 |
Low | 68.83 on 09/17/24 | 331.00 on 09/18/24 | 48.78 on 09/18/24 | 82.38 on 09/17/24 | 66.57 on 09/20/24 |
High | 78.00 on 09/16/24 | 339.00 on 09/18/24 | 50.41 on 09/17/24 | 84.65 on 09/19/24 | 75.37 on 09/17/24 |
1-Month | |||||
%Chg | -23.90% since 08/20/24 | +2.02% since 08/20/24 | +0.47% since 08/20/24 | +11.12% since 08/20/24 | -22.95% since 08/20/24 |
Low | 68.83 on 09/17/24 | 319.00 on 09/06/24 | 46.88 on 08/22/24 | 74.80 on 08/21/24 | 64.11 on 09/12/24 |
High | 94.64 on 08/21/24 | 339.00 on 09/18/24 | 50.75 on 09/04/24 | 84.89 on 09/12/24 | 88.59 on 08/21/24 |
3-Month | |||||
%Chg | -15.69% since 06/20/24 | +8.16% since 06/20/24 | +19.91% since 06/20/24 | +21.27% since 06/20/24 | -50.16% since 06/20/24 |
Low | 68.83 on 09/17/24 | 306.11 on 07/03/24 | 39.35 on 07/05/24 | 66.01 on 07/05/24 | 64.11 on 09/12/24 |
High | 94.85 on 08/20/24 | 346.85 on 07/25/24 | 51.19 on 07/29/24 | 84.89 on 09/12/24 | 138.07 on 06/25/24 |
6-Month | |||||
%Chg | -15.74% since 03/20/24 | +22.76% since 03/20/24 | -5.15% since 03/20/24 | +12.27% since 03/20/24 | -35.02% since 03/20/24 |
Low | 68.83 on 09/17/24 | 260.68 on 04/19/24 | 39.35 on 07/05/24 | 62.07 on 05/31/24 | 64.11 on 09/12/24 |
High | 94.85 on 08/20/24 | 346.85 on 07/25/24 | 54.47 on 03/28/24 | 84.89 on 09/12/24 | 170.47 on 05/24/24 |
Key Statistics | |||||
Market Capitalization, $K | 13,559,331 | 180,215,344 | 99,368,440 | 104,527,072 | 26,067,982 |
Shares Outstanding, K | 189,880 | 536,435 | 2,027,100 | 1,245,853 | 383,240 |
Annual Sales | 2,419,230,000 | 28,190,000,000 | 45,006,000,000 | 27,116,000,000 | 6,848,000,000 |
Annual Net Income | 167,650,000 | 6,717,000,000 | 8,025,000,000 | 5,665,000,000 | -4,714,000,000 |
Last Quarter Sales | 712,030,000 | 8,388,000,000 | 12,201,000,000 | 6,954,000,000 | 241,000,000 |
Last Quarter Net Income | 107,170,000 | 746,000,000 | 1,680,000,000 | 1,614,000,000 | -1,279,000,000 |
60-Month Beta | 0.32 | 0.61 | 0.46 | 0.18 | 1.67 |
Per-Share Information | |||||
Most Recent Earnings | 0.96 on 08/05/24 | 4.97 on 08/06/24 | 2.07 on 07/26/24 | 2.01 on 08/08/24 | -3.33 on 08/01/24 |
Latest Earnings Date | 11/06/24 | 10/29/24 | 10/31/24 | 11/05/24 | 11/07/24 |
Most Recent Dividend | N/A | 2.250 on 08/16/24 | 0.600 on 07/05/24 | 0.770 on 09/13/24 | N/A |
Next Ex-Dividends Date | N/A | 08/16/24 | 10/04/24 | 09/13/24 | N/A |
Ratios | |||||
Price/Earnings ttm | 39.97 | 17.90 | 36.31 | 17.85 | 0.00 |